Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19

by Magnè, Federica , Altosole, Tiziana , Scavone, Graziana , Sepulcri, Chiara , Bassetti, Matteo , Mirabella, Michele , Uras, Chiara , Mikulska, Malgorzata , Cittadini, Giuseppe , Filaci, Gilberto , Fenoglio, Daniela , Portunato, Federica , Baldi, Federico , Orsi, Andrea , Dentone, Chiara , Taramasso, Lucia , Giacobbe, Daniele Roberto

in Antibiotics / Antiviral drugs / Bacterial infections / Blood tests / Combination therapy / COVID-19 / COVID-19 vaccines / Creatinine / Cytokines / Fever / Hematology / immunocompromised / Leukocytes / Lymphoma / Medical imaging / Medicine / Monoclonal antibodies / Mortality / mRNA vaccines / nirmatrelvir/ritonavir / Patients / Pleural effusion / Pneumonia / salvage therapy / Serology / Severe acute respiratory syndrome coronavirus 2 / sotrovimab / Steroids / Tuberculosis / Viral infections

2023

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19

2023

Confirm

Do you wish to request the book?

Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19

2023

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19

Magnè, Federica,

Altosole, Tiziana,

Scavone, Graziana,

Sepulcri, Chiara,

Bassetti, Matteo,

Mirabella, Michele,

Uras, Chiara,

Mikulska, Malgorzata,

Cittadini, Giuseppe,

Filaci, Gilberto,

Fenoglio, Daniela,

Portunato, Federica,

Baldi, Federico,

Orsi, Andrea,

Dentone, Chiara,

Taramasso, Lucia,

Giacobbe, Daniele Roberto

2023

Overview

COVID-19 in immunocompromised patients is difficult to treat. SARS-CoV-2 interaction with the host immune system and the role of therapy still remains only partly understood. There are no data regarding the use of monoclonal antibodies and the combination of two antivirals in fighting viral replication and disease progression. We report the cases of two patients, both treated with rituximab for non-Hodgkin lymphoma and granulomatosis with polyangiitis, respectively, and both hospitalized for COVID-19 with positive SARS-CoV-2 RNAemia, who were successfully treated with a salvage combination therapy with sotrovimab, remdesivir and nirmatrelvir/ritonavir.

Share this book

Add to My Shelf

Publisher

Frontiers Media SA,Frontiers Media S.A

Subject

Antibiotics

/ Antiviral drugs

/ Bacterial infections

/ Blood tests

/ Combination therapy

/ COVID-19

/ COVID-19 vaccines